Yellow Fever Vaccine Suppliers & Bulk Manufacturers
Available Forms: Lyophilized powder, Injectable suspension
Available Strengths: 0.5 mL
Reference Brands: YF-VAX(US)
Category:
Vaccines
Yellow fever vaccine stimulates immunity by introducing a weakened virus, prompting the production of protective antibodies. It effectively prevents yellow fever, reduces severe illness and death, and supports long-term protection in travelers and endemic areas. Benefits include disease elimination, community immunity, and safeguarding populations from a potentially fatal viral infection.
Yellow Fever Vaccine is available in Lyophilized powder, Injectable suspension
and strengths such as 0.5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Yellow Fever Vaccine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Yellow Fever Vaccine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Yellow fever vaccine is approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, FDA approval requires extensive clinical data, though the vaccine is mainly used for travel immunization. In the EU, CE marking certifies conformity with in vitro diagnostic and medical regulations. The vaccine undergoes validation, stability testing, and quality audits, with comprehensive documentation including safety profiles, clinical trial results, and manufacturing practices. For licensing procedures, approved dossiers, and latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective yellow fever immunization essential for travelers and endemic regions worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing